DCTH
Delcath Systems, Inc.NASDAQHealthcare$9.63+0.73%ClosedMarket Cap: $334.6M
As of 2026-04-06
Valuation
P/E (TTM)
123.93
PEG
1.12
P/B
3.18
P/S
3.95
EV/EBITDA
114.69
DCF Value
$-159.22
FCF Yield
6.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.2%
Operating Margin
0.8%
Net Margin
3.2%
ROE
2.6%
ROA
2.2%
ROIC
0.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $20.7M | 85.5% | $-2.2M | $-1.9M | $-0.05 | — |
| FY 2025 | $85.2M | 86.2% | $660.0K | $2.7M | $0.07 | — |
| Q3 2025 | $20.6M | 87.2% | $-388.0K | $830.0K | $0.02 | — |
| Q2 2025 | $24.2M | 86.3% | $2.6M | $2.7M | $0.07 | — |
| Q1 2025 | $19.8M | 85.6% | $642.0K | $1.1M | $0.03 | — |
| Q4 2024 | $15.1M | 85.9% | $3.0M | $-3.4M | $-0.11 | — |
| FY 2024 | $37.2M | 83.4% | $-12.4M | $-26.4M | $-0.93 | — |
| Q3 2024 | $11.2M | 85.4% | $-1.3M | $1.9M | $0.06 | — |
| Q2 2024 | $7.8M | 80.4% | $-3.9M | $-13.7M | $-0.48 | — |
| Q1 2024 | $3.1M | 71.2% | $-10.3M | $-11.1M | $-0.45 | — |
| Q4 2023 | $539.0K | 68.3% | $-11.3M | $-11.1M | $-0.48 | — |
| FY 2023 | $2.1M | 69.2% | $-38.2M | $-47.7M | $-2.94 | — |